Porvac®亚单位疫苗在古巴两个种猪场上市后六年现场评价
本文报告古巴比那尔德里奥省两个猪遗传改良场使用Porvac®(含嵌合E2-CD154融合蛋白的第二代亚单位疫苗)替代猪瘟活疫苗的六年上市后随访。免疫后群体免疫力从50%升至100%,所有种猪均具保护性中和抗体滴度并维持六年;抗Erns阳性猪逐步减少至消失,10%种猪未检出CSFV RNA,提示两场无猪瘟病毒循环。
要点
- Porvac®免疫后两场群体免疫力由50%升至100%并维持六年。
- 所有种猪均产生保护性中和抗体滴度。
- 抗Erns阳性猪逐步减少至消失,10%种猪未检出CSFV RNA。
核心结论
- Porvac®在两个猪遗传改良场应用后实现并维持高水平群体免疫,六年内未见猪瘟病毒循环。
研究设计与样本
- 对古巴比那尔德里奥省两个猪遗传改良场使用Porvac®进行六年上市后随访。
主要发现
- 免疫后群体免疫力从50%升至100%,所有种猪均具保护性中和抗体滴度并维持六年。
- 抗Erns阳性猪在免疫后逐步减少直至消失。
- 10%种猪未检出CSFV RNA,提示两场无猪瘟病毒循环。
临床怎么用
- 在种猪场以Porvac®替代猪瘟活疫苗可维持高水平群体免疫并减少低毒力毒株难以检测的问题。
局限性
- 原文为两场六年随访,未报告对照设计及更广泛场群的推广数据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Classical swine fever (CSF) is one of the most important diseases affecting pigs. For years, the main strategy to control CSF outbreaks in endemic regions has been a combination of stamping out of pigs in the affected area and the application of modified live vaccines (MLV) to limit the spread of the disease. However, the implementation of non-optimal vaccination has been associated with emergence of low virulence classical swine fever virus (CSFV) strains that are difficult to detect and eliminate. Porvac® is a second-generation subunit vaccine containing chimeric E2-CD154 fusion protein. This vaccine is safe, provides a very rapid onset of protection and prevents vertical transmission. Because of these advantages, Porvac® has been proposed to replace MLV as part of the effort to eliminate CSFV from Cuba. Pig Genetic Development Farms (GDF) are an important part of pig production in Cuba. They maintain, develop improved hybrid lines and supply superior boars and gilts to intermediate farms. Here we present data from a six-year post-marketing follow-up of the use of Porvac® in two pig GDFs in the province of Pinar del Río. After Porvac® intervention, the herd immunity in these GDFs increased from 50% to 100%, with all the breeding stock showing protective neutralizing antibody titres, and this coverage was maintained over the six years evaluated. In addition, the number of pigs testing positive for anti-Erns was progressively reduced after vaccination until it disappeared. This, together with the absence of CSFV RNA in the 10% of the breeding stock, indicates that the two GDFs were free of CSF circulation during these years. To the best of our knowledge these results represent the most extensive follow-up of the field application of a subunit vaccine against CSF and confirm the potential of Porvac® to provide high quality and sustained herd immunity against CSF.
引用
- Sordo-Puga Y, Sardina-González T, Méndez-Orta MK, et al. Post-licensing evaluation of Porvac® subunit vaccine against classical swine fever in two pig genetic development farms in Cuba. Vaccine. 2026. PMID: 41797173. doi:10.1016/j.vaccine.2026.128386
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。